https://www.gynecologiconcology-online.net/article/S0090-8258(20)33660-X/fulltext

https://www.businesswire.com/news/home/20200716005844/en/Puma-Biotechnology-Licensing-Partner-Specialised-Therapeutics-Receives

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer 

https://www.annalsofoncology.org/article/S0923-7534(20)39833-1/fulltext 

Neratinib approved in China for early breast cancer 

https://www.biospace.com/article/releases/puma-biotechnology-licensing-partner-canbridge-pharmaceuticals-receives-marketing-approval-in-mainland-china-for-nerlynx-neratinib-for-extended-adjuvant-treatment-of-early-stage-her2-positive-breast-cancer/

Expert opinion on FDA approval of neratinib for metastatic breast cancer

https://www.onclive.com/publications/oncology-live/2020/vol-21-no8/application-of-neratinib-in-breast-cancer-broadens

https://www.onclive.com/onclive-tv/dr-lin-on-cns-activity-in-her2-directed-tkis-in-her2-positive-breast-cancer/

FDA Approves Neratinib Combo for HER2+ Breast Cancer

https://www.onclive.com/web-exclusives/fda-approves-neratinib-combo-for-her2-breast-cancer

Impact of Neratinib on CNS Metastases in Patients With HER2-Positive Metastatic Breast Cancer: Analysis of Data From Phase II/III Trials

https://www.clinicaloptions.com/oncology/conference-coverage/breast-cancer-dec-2019/breast-cancer/capsule-summary-slidesets/p2_20_01

https://www.onclive.com/login?redirect=onclive-tv/dr-anders-discusses-the-use-of-neratinibcapecitabine-for-her2positive-brain-metastases/

Key Trials Showcase the Utility of Neratinib in HER2+ Breast Cancer

https://www.onclive.com/web-exclusives/key-trials-showcase-the-utility-of-neratinib-in-her2-positive-breast-cancer?p=1